Lnc2Cancer

Experimentally Supported Human LncRNA and Cancer Associations Database

LncRNA centric

Cancer centric

Advanced search

Drug resistant

Circulating

Prognosis

Detail


   LncRNA Name lncRNA-LET
   Synonyms NPTN-IT1, lncRNA-LET
   Region GRCh38_15:73567012-73569294    Sequence
   Ensembl ENSG00000281183
   RefSeq NR_103844
   Circulating
   Drug-resisitant
   Prognostic
   MiRNA
   Variant
   TF
   Methylation
   Cancer Name bladder cancer
   ICD-0-3 C67  
   Methods qPCR, RIP, western blot etc.
   Sample BC tissues, cell lines (T24, 5637, J82, SW780, BIU87, ScaBER and UMUC3)
   Expression Pattern down-regulated
   Function Description

LET was the only lncRNA that was downregulated more than 2 folds in GEM-treated xenografts derived from both T24 and 5637 cells. The array results were further validated in these cell lines treated with or without GEM. reduced lncRNA-LET increased the NF90 protein stability, which in turn repressed biogenesis of miR-145 and subsequently resulted in accumulation of CSCs evidenced by the elevated levels of stemness markers HMGA2 and KLF4. UBC patients which displayed lower expression levels of lncRNA-LET and miR-145 had a reduced survival rate, whereas TGFB1 expression level did not show significant difference in clinical outcome.

   Pubmed ID 28839463
   Year 2017
   Title TGFB1 Promotes Gemcitabine Resistance through Regulating the LncRNA-LET/NF90/miR-145 Signaling Axis in Bladder Cancer
   External Links
   Links for  lncRNA-LET GenBank       HGNC       lncrnadb       Noncode
   Links for  bladder cancer Omim       Cosmic

CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.